Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Fourteen years of debate and workshops on the immunology of preeclampsia. Where are we now after the 2012 workshop?

Identifieur interne : 003898 ( PubMed/Corpus ); précédent : 003897; suivant : 003899

Fourteen years of debate and workshops on the immunology of preeclampsia. Where are we now after the 2012 workshop?

Auteurs : Pierre-Yves Robillard ; Gustaaf Dekker ; Gérard Chaouat

Source :

RBID : pubmed:23972718

English descriptors

Abstract

This paper depicts an overview of debates that have taken place during the 14 years of the International Workshops on Reproductive Immunology/Immunological Tolerance and Immunology of Preeclampsia. This 8th event in 2012 (Reunion island, overseas department of France in the Indian Ocean) witnessed a consensus among immunologists on the key role of regulatory T-cells in the orchestration of trophoblastic invasion at the maternal-fetal interface, while they represent some 10% of the immunological cellular repertoire at the site of implantation (NK cells representing 70%). On the vascular side, the upregulation of carbon monoxide CO, metabolite of heme oxygenase-1 (HO-1; by inhibiting soluble Flt-1, SFlt-1, and soluble endoglin, SEng, release), explains the very promising protective and potentially therapeutic effect of pravastatin in preeclampsia and the paradoxical strong protective effect of cigarette smoking on preeclampsia. Finally, there was, through a study performed on Mauritius island a great interest in the inositol phosphoglycans P-type (IPG-P) as a reliable, cheap, and predictive urinary test in preeclamptic women (a few weeks before the clinical onset of the disease). Besides the interest of a specific test, IPG-P may also partially explain the global endothelial cell disease encountered in preeclampsia. Furthermore, the Appendix of this paper lists the programs of all the workshops that have taken place since 1998.

DOI: 10.1016/j.jri.2013.06.003
PubMed: 23972718

Links to Exploration step

pubmed:23972718

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Fourteen years of debate and workshops on the immunology of preeclampsia. Where are we now after the 2012 workshop?</title>
<author>
<name sortKey="Robillard, Pierre Yves" sort="Robillard, Pierre Yves" uniqKey="Robillard P" first="Pierre-Yves" last="Robillard">Pierre-Yves Robillard</name>
<affiliation>
<nlm:affiliation>Neonatology, Centre d'Etudes Périnatales Océan Indien, Centre Hospitalier Universitaire Réunion, BP 350, 97448 Saint-Pierre cedex, Reunion. Electronic address: robillard.reunion@wanadoo.fr.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dekker, Gustaaf" sort="Dekker, Gustaaf" uniqKey="Dekker G" first="Gustaaf" last="Dekker">Gustaaf Dekker</name>
<affiliation>
<nlm:affiliation>Head Women's and Children's Division, Lyell McEwin Hospital, University of Adelaide, Haydown Road, Elizabeth Vale, 5112 South Australia, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chaouat, Gerard" sort="Chaouat, Gerard" uniqKey="Chaouat G" first="Gérard" last="Chaouat">Gérard Chaouat</name>
<affiliation>
<nlm:affiliation>INSERM U 976, Pavillon Bazin, Hôpital Saint-Louis, 75010 Paris, France.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:23972718</idno>
<idno type="pmid">23972718</idno>
<idno type="doi">10.1016/j.jri.2013.06.003</idno>
<idno type="wicri:Area/PubMed/Corpus">003898</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003898</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Fourteen years of debate and workshops on the immunology of preeclampsia. Where are we now after the 2012 workshop?</title>
<author>
<name sortKey="Robillard, Pierre Yves" sort="Robillard, Pierre Yves" uniqKey="Robillard P" first="Pierre-Yves" last="Robillard">Pierre-Yves Robillard</name>
<affiliation>
<nlm:affiliation>Neonatology, Centre d'Etudes Périnatales Océan Indien, Centre Hospitalier Universitaire Réunion, BP 350, 97448 Saint-Pierre cedex, Reunion. Electronic address: robillard.reunion@wanadoo.fr.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dekker, Gustaaf" sort="Dekker, Gustaaf" uniqKey="Dekker G" first="Gustaaf" last="Dekker">Gustaaf Dekker</name>
<affiliation>
<nlm:affiliation>Head Women's and Children's Division, Lyell McEwin Hospital, University of Adelaide, Haydown Road, Elizabeth Vale, 5112 South Australia, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chaouat, Gerard" sort="Chaouat, Gerard" uniqKey="Chaouat G" first="Gérard" last="Chaouat">Gérard Chaouat</name>
<affiliation>
<nlm:affiliation>INSERM U 976, Pavillon Bazin, Hôpital Saint-Louis, 75010 Paris, France.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of reproductive immunology</title>
<idno type="eISSN">1872-7603</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Congresses as Topic</term>
<term>Consensus</term>
<term>Embryo Implantation (immunology)</term>
<term>Female</term>
<term>Humans</term>
<term>Killer Cells, Natural (immunology)</term>
<term>Pre-Eclampsia (immunology)</term>
<term>Pregnancy</term>
<term>T-Lymphocytes, Regulatory (immunology)</term>
<term>Trophoblasts (immunology)</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Embryo Implantation</term>
<term>Killer Cells, Natural</term>
<term>Pre-Eclampsia</term>
<term>T-Lymphocytes, Regulatory</term>
<term>Trophoblasts</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Congresses as Topic</term>
<term>Consensus</term>
<term>Female</term>
<term>Humans</term>
<term>Pregnancy</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">This paper depicts an overview of debates that have taken place during the 14 years of the International Workshops on Reproductive Immunology/Immunological Tolerance and Immunology of Preeclampsia. This 8th event in 2012 (Reunion island, overseas department of France in the Indian Ocean) witnessed a consensus among immunologists on the key role of regulatory T-cells in the orchestration of trophoblastic invasion at the maternal-fetal interface, while they represent some 10% of the immunological cellular repertoire at the site of implantation (NK cells representing 70%). On the vascular side, the upregulation of carbon monoxide CO, metabolite of heme oxygenase-1 (HO-1; by inhibiting soluble Flt-1, SFlt-1, and soluble endoglin, SEng, release), explains the very promising protective and potentially therapeutic effect of pravastatin in preeclampsia and the paradoxical strong protective effect of cigarette smoking on preeclampsia. Finally, there was, through a study performed on Mauritius island a great interest in the inositol phosphoglycans P-type (IPG-P) as a reliable, cheap, and predictive urinary test in preeclamptic women (a few weeks before the clinical onset of the disease). Besides the interest of a specific test, IPG-P may also partially explain the global endothelial cell disease encountered in preeclampsia. Furthermore, the Appendix of this paper lists the programs of all the workshops that have taken place since 1998.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">23972718</PMID>
<DateCreated>
<Year>2014</Year>
<Month>03</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>03</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1872-7603</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>101-102</Volume>
<PubDate>
<Year>2014</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Journal of reproductive immunology</Title>
<ISOAbbreviation>J. Reprod. Immunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Fourteen years of debate and workshops on the immunology of preeclampsia. Where are we now after the 2012 workshop?</ArticleTitle>
<Pagination>
<MedlinePgn>62-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jri.2013.06.003</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0165-0378(13)00080-6</ELocationID>
<Abstract>
<AbstractText>This paper depicts an overview of debates that have taken place during the 14 years of the International Workshops on Reproductive Immunology/Immunological Tolerance and Immunology of Preeclampsia. This 8th event in 2012 (Reunion island, overseas department of France in the Indian Ocean) witnessed a consensus among immunologists on the key role of regulatory T-cells in the orchestration of trophoblastic invasion at the maternal-fetal interface, while they represent some 10% of the immunological cellular repertoire at the site of implantation (NK cells representing 70%). On the vascular side, the upregulation of carbon monoxide CO, metabolite of heme oxygenase-1 (HO-1; by inhibiting soluble Flt-1, SFlt-1, and soluble endoglin, SEng, release), explains the very promising protective and potentially therapeutic effect of pravastatin in preeclampsia and the paradoxical strong protective effect of cigarette smoking on preeclampsia. Finally, there was, through a study performed on Mauritius island a great interest in the inositol phosphoglycans P-type (IPG-P) as a reliable, cheap, and predictive urinary test in preeclamptic women (a few weeks before the clinical onset of the disease). Besides the interest of a specific test, IPG-P may also partially explain the global endothelial cell disease encountered in preeclampsia. Furthermore, the Appendix of this paper lists the programs of all the workshops that have taken place since 1998.</AbstractText>
<CopyrightInformation>Copyright © 2013. Published by Elsevier Ireland Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Robillard</LastName>
<ForeName>Pierre-Yves</ForeName>
<Initials>PY</Initials>
<AffiliationInfo>
<Affiliation>Neonatology, Centre d'Etudes Périnatales Océan Indien, Centre Hospitalier Universitaire Réunion, BP 350, 97448 Saint-Pierre cedex, Reunion. Electronic address: robillard.reunion@wanadoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dekker</LastName>
<ForeName>Gustaaf</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Head Women's and Children's Division, Lyell McEwin Hospital, University of Adelaide, Haydown Road, Elizabeth Vale, 5112 South Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chaouat</LastName>
<ForeName>Gérard</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>INSERM U 976, Pavillon Bazin, Hôpital Saint-Louis, 75010 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>08</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Ireland</Country>
<MedlineTA>J Reprod Immunol</MedlineTA>
<NlmUniqueID>8001906</NlmUniqueID>
<ISSNLinking>0165-0378</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D003226" MajorTopicYN="N">Congresses as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010064" MajorTopicYN="N">Embryo Implantation</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D050378" MajorTopicYN="N">T-Lymphocytes, Regulatory</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014327" MajorTopicYN="N">Trophoblasts</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Epidemiology</Keyword>
<Keyword MajorTopicYN="N">Immunology</Keyword>
<Keyword MajorTopicYN="N">Inositol phospho glycans</Keyword>
<Keyword MajorTopicYN="N">Preeclampsia</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>03</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2013</Year>
<Month>06</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>8</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>8</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>11</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23972718</ArticleId>
<ArticleId IdType="pii">S0165-0378(13)00080-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.jri.2013.06.003</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003898 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003898 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:23972718
   |texte=   Fourteen years of debate and workshops on the immunology of preeclampsia. Where are we now after the 2012 workshop?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:23972718" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024